TAVNEOS
TAVNEOS
Approved
DIN Number
02526662
Drug Class
Human
Market Date
Nov 4, 2022
Company
HC
vifor fresenius medical care renal pharma ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526662
AIG Number0163561001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AJ05 AVACOPAN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification90:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AVACOPANActive
Strength: 10 MG
Monograph: AVACOPAN